Carole Beaulieu

发表

Identification of a novel series of potent RON receptor tyrosine kinase inhibitors.

C. Maroun, A. Macleod, S. Raeppel, 2010, Bioorganic & medicinal chemistry letters.

Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa

A. Wong, J. Overhage, C. Beaulieu, 2023, Antibiotics.

N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.

Sylvain Lefebvre, M. Robert, Nancy Z. Zhou, 2009, Bioorganic & medicinal chemistry letters.

Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases.

M. Robert, A. Macleod, A. Vaisburg, 2008, Bioorganic & medicinal chemistry letters.

N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases.

A. Macleod, Nancy Z. Zhou, S. Raeppel, 2009, Bioorganic & medicinal chemistry letters.

N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.

M. Robert, Nancy Z. Zhou, S. Raeppel, 2009, Bioorganic & medicinal chemistry letters.

(2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors

A. Kalita, A. Macleod, O. Moradei, 2004 .

Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.

A. Kalita, A. Macleod, S. Leit, 2002, Cancer research.

Design and synthesis of a novel class of histone deacetylase inhibitors.

S. Leit, S. Fréchette, G. Bouchain, 2001, Bioorganic & medicinal chemistry letters.

Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.

Daniel Delorme, A. Kalita, M. Robert, 2003, Journal of medicinal chemistry.

Identification of potent and selective VEGFR receptor tyrosine kinase inhibitors having new amide isostere headgroups.

A. Macleod, S. Raeppel, F. Gaudette, 2010, Bioorganic & medicinal chemistry letters.